Educational Grant Support

Clinical Research

  • Efficacy & Safety of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel vs. Vehicle Gel for the Treatment of Acne and Acne-Induced Post Inflammatory Hyperpigmentation in Patients with Skin of Color (Acne & PIH Study). Medicis 2009.
  • A Multicenter, Double-Masked, Randomized, Parallel-Group Study Assessing the Safety and Efficacy of Once Daily Application of Bimatoprost Solution 0.03% Compared to Vehicle in Increasing Overall Eyelash Prominence in African Americans with Eyelash Hypotrichosis. Allergan 2009.
  • Safety and Efficacy Comparison of Cleanse & Treat Pads (5% benzoyl peroxide pad and 2% salicylic acid pad) versus Benzaclin (benzoyl peroxide 5% and clindmycin 1% topical gel) in Subjects Diagnosed with Mild to Moderate Facial Acne Vulgaris. Quinnova 2009.
  • Comparative Efficacy and Safety of Tretinoin 0.025% Cream Used in Combination with Aczone Gel and Tretinoin 0.025% Cream Monotherapy in the Treatment of Moderate to Severe Facial Acne Vulgaris. Allergan 2009.
  • A Phase II, Randomized, Double-Blind Vehicle-Controlled Cross-Over Study to Determine the Anti-Pruritic Efficacy, Safety and Local Dermal Toleration of SRD174 Cream in Subjects with Atopic Dermatitis. Serentis 2009.
  • An Open-label, Multi-Center, Prospective, Postmarket Study to Assess the Safety and Effectiveness of EVOLENCE in Facial Augmentation of Subjects with Fitzpatrick Skin Color Types IV, V, and VI. Colbar LifeScience Ltd. 2009.
  • Treatment of Post-Inflammatory Hyperpigmentation (PIH) & Melasma in Skin Type IV-VI Using the Palomar StarLux with Lux V, Lux Y and LuxRs Hand-Pieces. Palomar Medical, Inc. 2007.
  • Post-marketing study of Radiesse for the treatment of Nasolabial Folds in persons of color. Bioform Medical, Inc. 2007.
  • A Phase 3 / 4, Multicenter, Open-Label Extension Study to Assess the Long-Term Safety of Repeat Administrations of Reloxin in the Treatment of Glabellar Lines. Medicis 2007.
  • A Multi-Center, Randomized, Double-Blind, Parallel-Group Study to Demonstrate the Efficacy and Safety of Adapalne/Benzoyl Peroxide Topical Gel Compared with Adapalene Topical Gel, 0.1%; Benzoyl Peroxide Topical Gel, 2.5% and Topical Gel Vehicle in Subjects with Acne Vulgaris. Galderma 2005.
  • A Randomized, Comparative, Evaluator-Blinded Study on the Safety of Restylane and Perlane in Patients with Fitzpatrick Skin Types 4, 5 or 6. Medicis 2005.
  • Multicenter, "split face," comparative Phase IV trial to demonstrate the non-inferiority of Solage® Solution (mequinol 2%, tretinoin 0.01%) to hydroquinone 4% cream in the treatment of Subjects with bilateral, mild to moderate postinflammatory Hyperpigmentation (PIH) of the face. Barrier Therapeutics, Inc. 2005.
  • Efficacy and Safety of Tri-Luma in the Treatment of Patients with Cutaneous Melanosis of the Face (Melasma). Hill Dermaceuticals, Inc.
  • Placebo Controlled Phase-IV Study to Evaluate the Benefit of Tazarotene 0.1% Gel in the Treatment of Active Pseudofolliculitis Barbae (PFB) in Patients with Skin of Color. Allergan.
  • Placebo Controlled Phase-IV Study of Efficacy of Tazarotene Cream 0.1% in the Treatment of Acne Keloidalis Nuchae. Allergan.
  • Development and Validation of the Hyperpigmentation Scale. Galderma.
  • Placebo Controlled Phase-IV Study of Efficacy and Tolerability of Benzaclin Gel in the Treatment of Pseudofolliculitis Barbae. Dermik.
  • Safety and Efficacy of Dapsone in the Treatment of Facial Acne. Atrix.
  • Safety and Efficacy of Metrolotion in the Treatment of Seborrheic Dermatitis. Galderma.
  • Safety and Efficacy of Loprox Shampoo for Seborrheic Dermatitis. Medicis.
  • Safety and Efficacy of Tri-Luma for the Treatment of Pseudofolliculitis Barbae. Galderma.
  • Safety and Efficacy of Etanercept in the Treatment of Subjects with Psoriasis. Amgen.